Structure via PubChem · Public domain (PubChem)
amphotericin B
Sign in to saveAlso known as APT370, AMPH-b, C-AmB, liposomal amphotericin B
chemical compound
Key facts
- Trade names
- Fungizone, Mysteclin-F, AmBisome and other
- Ahfs drugs com
- Monograph
- Medlineplus
- a682643
- License data
- United States</span>"}]]}'>US DailyMed : Amphotericin_B
- Pregnancy category
- Australia</span>"}]]}'>AU : B2
- Routes of administration
- Intravenous infusion
- Atc code
- A01AB04 ( WHO ) A07AA07 ( WHO ), G01AA03 ( WHO ), J02AA01 ( WHO )
- Legal status
- United States</span>"}]]}'>US : ℞-only In general: ℞ (Prescription only)
- Bioavailability
- 100% (IV) low (oral)
- Metabolism
- kidney
- Elimination half life
- Initial phase: 24 hours Second phase: approximately 15 days
- Excretion
- 40% found in urine after single cumulated over several days Biliary excretion is also important
- Cas number
- 1397-89-3
- Drugbank
- DB00681
- Unii
- 7XU7A7DROE
- Kegg
- D00203
- Chebi
- CHEBI:2682
- Chembl
- ChEMBL267345
via Wikipedia infobox
Chemical data
- Formula
- C47H73NO17
- Molecular weight
- 924.1 g/mol
- IUPAC name
- (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-azaniumyl-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylate
- SMILES
- C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)[O-])O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)[NH3+])O
- InChIKey
- APKFDSVGJQXUKY-INPOYWNPSA-N
- XLogP
- 0.6
- Polar surface area
- 324 Ų
- H-bond donors
- 11
- H-bond acceptors
- 17
- Formal charge
- 0
via PubChem
Research
28,962 papers- Amphotericin B.Applied microbiology and biotechnology · 2005
- Amphotericin B--specifics of administration.Modern treatment · 1970
- [Clinical safety of liposomal amphotericin B].Revista iberoamericana de micologia · 2021
- Amphotericin B lipid complex for the treatment of invasive fungal infections.Expert opinion on pharmacotherapy · 2003
- Amphotericin B and its lipid formulations.Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses · 1994
via PubMed
Wikidata facts
- Mass
- 923.488
Show 5 more facts
- chemical formula
- C₄₇H₇₃NO₁₇
- World Health Organisation international non-proprietary name
- amphotericin B
- isomeric SMILES
- C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O
- canonical SMILES
- CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O
- defined daily dose
- 0.4
Sources (6)
via Wikidata · CC0
~17 min read
Article
Amphotericin B is an antifungal medication used for serious fungal infections and leishmaniasis. The fungal infections it is used to treat include mucormycosis, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, and cryptococcosis. It is sometimes used as a drug of last resort for primary amoebic meningoencephalitis. For certain infections it is given with flucytosine. It is typically given intravenously.
Common side effects include a reaction with fever, chills, and headaches soon after the medication is given, as well as kidney problems. Allergic symptoms including anaphylaxis may occur. Other serious side effects include low blood potassium and myocarditis (inflammation of the heart). It appears to be relatively safe in pregnancy. There is a lipid formulation that has a lower risk of side effects. It is in the polyene class of medications and works in part by interfering with the cell membrane of the fungus.